VeraDermics
Veradermics is a dermatology-focused biopharmaceutical company that develops treatments for common skin and hair conditions. Its lead drug candidate, VDPHL01, is an extended-release oral minoxidil being tested in Phase 3 clinical trials for pattern hair loss in both women and men. The company also has pipeline programs targeting conditions such as common warts, molluscum contagiosum, and atopic dermatitis.
Domain
veradermics.com
Country
United StatesIndustry
Health CareEmployees
1-10
Last Funding
$150.0M
Founded
2019
Tech Stack (18 technologies)
Frequently Asked Questions
What technologies does VeraDermics use?+
VeraDermics uses 18 technologies including Bootstrap, Google Tag Manager, WP Rocket.
What industry is VeraDermics in?+
VeraDermics operates in the Health Care industry.
Where is VeraDermics based?+
VeraDermics is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026